155 related articles for article (PubMed ID: 31187666)
1. Radiotherapy activates autophagy to increase CD8
Zeng H; Zhang W; Gong Y; Xie C
J Int Med Res; 2019 Aug; 47(8):3818-3830. PubMed ID: 31187666
[TBL] [Abstract][Full Text] [Related]
2. The positive prognostic effect of stromal CD8+ tumor-infiltrating T cells is restrained by the expression of HLA-E in non-small cell lung carcinoma.
Talebian Yazdi M; van Riet S; van Schadewijk A; Fiocco M; van Hall T; Taube C; Hiemstra PS; van der Burg SH
Oncotarget; 2016 Jan; 7(3):3477-88. PubMed ID: 26658106
[TBL] [Abstract][Full Text] [Related]
3. CD4/CD8 co-expression shows independent prognostic impact in resected non-small cell lung cancer patients treated with adjuvant radiotherapy.
Hald SM; Bremnes RM; Al-Shibli K; Al-Saad S; Andersen S; Stenvold H; Busund LT; Donnem T
Lung Cancer; 2013 May; 80(2):209-15. PubMed ID: 23384671
[TBL] [Abstract][Full Text] [Related]
4. A randomized phase II study of radiation induced immune boost in operable non-small cell lung cancer (RadImmune trial).
Safi S; Beckhove P; Warth A; Benner A; Roeder F; Rieken S; Debus J; Dienemann H; Hoffmann H; Huber PE
BMC Cancer; 2015 Dec; 15():988. PubMed ID: 26686362
[TBL] [Abstract][Full Text] [Related]
5. Determination of poor prognostic immune features of tumour microenvironment in non-smoking patients with lung adenocarcinoma.
Kinoshita T; Kudo-Saito C; Muramatsu R; Fujita T; Saito M; Nagumo H; Sakurai T; Noji S; Takahata E; Yaguchi T; Tsukamoto N; Hayashi Y; Kaseda K; Kamiyama I; Ohtsuka T; Tomizawa K; Shimoji M; Mitsudomi T; Asamura H; Kawakami Y
Eur J Cancer; 2017 Nov; 86():15-27. PubMed ID: 28950145
[TBL] [Abstract][Full Text] [Related]
6. Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer.
Woo EY; Chu CS; Goletz TJ; Schlienger K; Yeh H; Coukos G; Rubin SC; Kaiser LR; June CH
Cancer Res; 2001 Jun; 61(12):4766-72. PubMed ID: 11406550
[TBL] [Abstract][Full Text] [Related]
7. The absence of HLA class I expression in non-small cell lung cancer correlates with the tumor tissue structure and the pattern of T cell infiltration.
Perea F; Bernal M; Sánchez-Palencia A; Carretero J; Torres C; Bayarri C; Gómez-Morales M; Garrido F; Ruiz-Cabello F
Int J Cancer; 2017 Feb; 140(4):888-899. PubMed ID: 27785783
[TBL] [Abstract][Full Text] [Related]
8. Increased proteinase inhibitor-9 (PI-9) and reduced granzyme B in lung cancer: mechanism for immune evasion?
Soriano C; Mukaro V; Hodge G; Ahern J; Holmes M; Jersmann H; Moffat D; Meredith D; Jurisevic C; Reynolds PN; Hodge S
Lung Cancer; 2012 Jul; 77(1):38-45. PubMed ID: 22387007
[TBL] [Abstract][Full Text] [Related]
9. LXR activation radiosensitizes non-small cell lung cancer by restricting myeloid-derived suppressor cells.
Liang H; Shen X
Biochem Biophys Res Commun; 2020 Jul; 528(2):330-335. PubMed ID: 32448508
[TBL] [Abstract][Full Text] [Related]
10. Inhibition on Numb/Notch signal pathway enhances radiosensitivity of lung cancer cell line H358.
Song SG; Yu HY; Ma YW; Zhang F; Xu XY
Tumour Biol; 2016 Oct; 37(10):13705-13719. PubMed ID: 27476167
[TBL] [Abstract][Full Text] [Related]
11. Spontaneous antibody, and CD4 and CD8 T-cell responses against XAGE-1b (GAGED2a) in non-small cell lung cancer patients.
Ohue Y; Eikawa S; Okazaki N; Mizote Y; Isobe M; Uenaka A; Fukuda M; Old LJ; Oka M; Nakayama E
Int J Cancer; 2012 Sep; 131(5):E649-58. PubMed ID: 22109656
[TBL] [Abstract][Full Text] [Related]
12. Prognostic effect of epithelial and stromal lymphocyte infiltration in non-small cell lung cancer.
Al-Shibli KI; Donnem T; Al-Saad S; Persson M; Bremnes RM; Busund LT
Clin Cancer Res; 2008 Aug; 14(16):5220-7. PubMed ID: 18698040
[TBL] [Abstract][Full Text] [Related]
13. Posttreatment Immune Parameters Predict Cancer Control and Pneumonitis in Stage I Non-Small-Cell Lung Cancer Patients Treated With Stereotactic Ablative Radiotherapy.
Zheng Y; Shi A; Wang W; Yu H; Yu R; Li D; Xu B; Ma H; You J; Zhao D; Jiang L; Geng J; Zhu G
Clin Lung Cancer; 2018 Jul; 19(4):e399-e404. PubMed ID: 29519614
[TBL] [Abstract][Full Text] [Related]
14. Infiltration of CD8+ T cells in non-small cell lung cancer is associated with dedifferentiation of cancer cells, but not with prognosis.
Mori M; Ohtani H; Naito Y; Sagawa M; Sato M; Fujimura S; Nagura H
Tohoku J Exp Med; 2000 Jun; 191(2):113-8. PubMed ID: 10946920
[TBL] [Abstract][Full Text] [Related]
15. CD103+CD8+ Lymphocytes Characterize the Immune Infiltration in a Case With Pseudoprogression in Squamous NSCLC.
Rocha P; Hardy-Werbin M; Naranjo D; Taus Á; Rodrigo M; Zuccarino F; Roth R; Wood O; Ottensmeier CH; Arriola E
J Thorac Oncol; 2018 Oct; 13(10):e193-e196. PubMed ID: 29775806
[No Abstract] [Full Text] [Related]
16. Loss of antigen-presenting molecules (MHC class I and TAP-1) in lung cancer.
Korkolopoulou P; Kaklamanis L; Pezzella F; Harris AL; Gatter KC
Br J Cancer; 1996 Jan; 73(2):148-53. PubMed ID: 8546899
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-35 Suppresses the Antitumor Activity of T Cells in Patients with Non-Small Cell Lung Cancer.
Wang HM; Zhang XH; Feng MM; Qiao YJ; Ye LQ; Chen J; Fan FF; Guo LL
Cell Physiol Biochem; 2018; 47(6):2407-2419. PubMed ID: 29991058
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Significance of Programmed Cell Death Ligand 1 (PD-L1), CD8+ Tumor-Infiltrating Lymphocytes and p53 in Non-Small Cell Lung Cancer: An Immunohistochemical Study.
Rashed HE; Abdelrahman AE; Abdelgawad M; Balata S; Shabrawy ME
Turk Patoloji Derg; 2017; 1(1):211-222. PubMed ID: 28832075
[TBL] [Abstract][Full Text] [Related]
19. Analysis of cytotoxic T lymphocytes and Fas/FasL in Japanese patients with non-small cell lung cancer associated with HLA-A2.
Yoshimura C; Nomura S; Kanazawa S; Kuwana M; Muramatsu M; Yamaguchi K; Fukuhara S
J Cancer Res Clin Oncol; 2002 Nov; 128(11):581-8. PubMed ID: 12458337
[TBL] [Abstract][Full Text] [Related]
20. Absence of PD-L1 expression on tumor cells in the context of an activated immune infiltrate may indicate impaired IFNγ signaling in non-small cell lung cancer.
Theelen WSME; Kuilman T; Schulze K; Zou W; Krijgsman O; Peters DDGC; Cornelissen S; Monkhorst K; Sarma P; Sumiyoshi T; Amler LC; Willems SM; Blaauwgeers JLG; van Noesel CJM; Peeper DS; van den Heuvel MM; Kowanetz M
PLoS One; 2019; 14(5):e0216864. PubMed ID: 31125352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
